Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Top Smart Score Stocks

STOCKS

Research Tools

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Economic Indicators

Economic Indicators Center

Inflation Rate

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Popular

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Corona

CoronaNovavax: Street Underestimating Anticipated Strong Q2 and Outlook, Says Analyst

2y ago

NVAX

PremiumCorona

Is Moderna Stock a Buy Following Pediatric Covid-19 Vaccine Data? Analyst Weighs In

3y ago

PFE

BNTX

PremiumCorona

Novavax: Rising Cases Could Lead to Faster Uptake of Covid-19 Vaccine

3y ago

NVAX

PremiumCorona

Novavax: Covid-19 Vaccine Has Good Odds for EUA Approval, Says Analyst

3y ago

NVAX

PremiumCorona

Vaxart Stock: Awaiting Platform Validation for the Bull-Case to Kick In

3y ago

VXRT

PremiumCoronaIn Search of a Better Covid Vaccine, This Analyst Taps Ocugen

3y ago

Novavax Stock Could Hit $315, Says Analyst

Premium

Corona

Novavax Stock Could Hit $315, Says Analyst

3y ago

Is Gritstone Stock a Buy Right Now? This Is What You Need to Know

Premium

Corona

Is Gritstone Stock a Buy Right Now? This Is What You Need to Know

3y ago

PremiumCorona

Is 15% Potential Upside Good Enough to Risk Buying Inovio Stock? Analyst Weighs In

3y ago

PremiumCorona

Why This Analyst Sees Over 80% Upside Potential for Vaxart Stock

3y ago

VXRT

PremiumCorona

Moderna Stock Is Overvalued by 30%, Says JPMorgan

3y ago

PremiumCorona

Novavax: Analysts Applaud the Latest Developments

3y ago

PremiumCoronaOcugen’s Covid-19 Vaccine Might Have One up on mRNA Vaccines

3y ago

Pfizer Vaccine Less Effective on Omicron in South Africa

Premium

Corona

Pfizer Vaccine Less Effective on Omicron in South Africa

3y ago

NASDAQ

Moderna: Too Early to Tell Whether Flu Vaccine Has Differentiating Features

Premium

Corona

Moderna: Too Early to Tell Whether Flu Vaccine Has Differentiating Features

3y ago

PremiumCorona

Moderna Accelerates COVID-19 Vaccine Supply to COVAX

3y ago

NASDAQ

PremiumCorona

Moderna Stock Dips Again; Valuation Remains Steep

3y ago

NASDAQ

PremiumCorona

AstraZeneca Lands FDA Authorization; What Next?

3y ago

NASDAQ

PremiumCorona

Moderna Takes a Hit Against Omicron

3y ago

NASDAQ

PremiumCoronaModerna to Supply Additional COVID-19 Vaccines to the UK

3y ago

NASDAQ

Novavax: Covid-19 Vaccine’s Rollout Could Play Part in Combating Omicron Variant

Premium

Corona

Novavax: Covid-19 Vaccine’s Rollout Could Play Part in Combating Omicron Variant

3y ago

Ocugen: IND Halt Not a Concern for Covaxin, Says Analyst

Premium

Corona

Ocugen: IND Halt Not a Concern for Covaxin, Says Analyst

3y ago

Corona

Trending

Indices

Stocks

ETFs